10-Q Filing

ACUTUS MEDICAL, INC. CIK: 1522860 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001193125-20-249223`
Period End Date	20200630
Filing Date	20200918
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	d49972d10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 68 Cash Flow Statement 85 Stockholders Equity 34

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.30M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$62.35M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$5.04M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$263.00K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$860.00K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$8.42M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.27M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$2.51M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	775,403.00	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	695,902.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.32M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	695,902.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.82M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	775,403.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$46.44M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$82.46M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.43M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$2.34M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$2.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.89M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.11M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$95.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$87.00K	USD	Point-in-time
Total assets	`Assets`	$72.03M	USD	Point-in-time
Total assets	`Assets`	$105.45M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.08M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$10.08M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.04M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$3.50M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$8.20M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$833.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$882.00K	USD	Point-in-time
Common and preferred stock warrant liability	`CommonAndPreferredStockWarrantLiability`	$8.92M	USD	Point-in-time
Common and preferred stock warrant liability	`CommonAndPreferredStockWarrantLiability`	$10.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.29M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$2.05M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.59M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$38.56M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$38.24M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$4.00M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$5.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$75.44M	USD	Point-in-time
Total liabilities	`Liabilities`	$77.91M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of each of June 30, 2020 and December 31, 2019; 775,403 and 695,902 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of each of June 30, 2020 and December 31, 2019; 775,403 and 695,902 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$33.25M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$36.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-259.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-300.32M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.00K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-145.97M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$72.03M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$105.45M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.13M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$734.00K	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.52M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.72M	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$2.44M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.61M	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$2.66M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.86M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$16.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.62M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.25M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.93M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.02M	USD	2 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-635.00K	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$1.58M	USD	2 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$20.60M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$39.78M	USD	2 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$25.25M	USD	2 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$14.61M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-19.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-13.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.06M	USD	2 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.45M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$2.45M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.87M	USD	2 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$605.00K	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.40M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.40M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$208.00K	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$370.00K	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$143.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$95.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$13.77M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.72M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.37M	USD	1 Quarter
Interest expense	`InterestExpense`	$19.51M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-21.31M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-3.73M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-4.23M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-16.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-45.04M	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$6.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$7.00K	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-41.00K	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-14.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$96.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.00K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.11M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-30.34M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-41.26M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-45.05M	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-68.21	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-32.24	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-45.70	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-58.16	USD	2 Qtrs
Weighted-average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	660,333.00	shares	2 Qtrs
Weighted-average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	663,972.00	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	719,421.00	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	709,961.00	shares	2 Qtrs

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-45.04M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-41.29M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$600.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$978.00K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$500.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.14M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$220.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$100.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.36M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$2.90M	USD	2 Qtrs
Accretion of discounts/(amortization of premiums) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.00K	USD	2 Qtrs
Accretion of discounts/(amortization of premiums) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$19.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$314.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$17.31M	USD	2 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$336.00K	USD	2 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$312.00K	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.40M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.40M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.45M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$2.45M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.87M	USD	2 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$605.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.58M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$280.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$597.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.62M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.96M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-666.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$12.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.68M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.29M	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.81M	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$155.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-349.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-411.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-34.76M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.08M	USD	2 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$22.21M	USD	2 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	2 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$8.10M	USD	2 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$40.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$316.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.45M	USD	2 Qtrs
Cash paid, net of cash acquired for the Rhythm Xience Acquisition	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$52.65M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.42M	USD	2 Qtrs
Proceeds from issuance of debt and warrants	`ProceedsFromIssuanceOfDebtAndWarrants`	$77.00M	USD	2 Qtrs
Repayment of debt	`ProceedsFromRepaymentsOfDebt`	$-15.00M	USD	2 Qtrs
Payment of issuance and extinguishment costs related to debt	`PaymentsOfDebtExtinguishmentCosts`	$2.33M	USD	2 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.62M	USD	2 Qtrs
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$38.23M	USD	2 Qtrs
Payment of deferred offering costs	`PaymentsOfDeferredOfferingCosts`	$701.00K	USD	2 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$205.00K	USD	2 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$57.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.12M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$97.95M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.00K	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-12.00K	USD	2 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$58.43M	USD	2 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.84M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$68.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$68.21M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$2.38M	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$1.17M	USD	2 Qtrs
Issuance of Series D convertible preferred stock for 2018 Convertible Notes and 2019 Convertible Notes	`IssuanceOfSeriesDConvertiblePreferredStockFor2018ConvertibleNotesAnd2019ConvertibleNotes`	$68.48M	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	2 Qtrs
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$41.00K	USD	2 Qtrs
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$-7.00K	USD	2 Qtrs
Warrants issued in conjunction with OrbiMed debt	`WarrantsIssuedInConjunctionWithOrbrimedDebt`	$872.00K	USD	2 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightofuseassetsExchangedForOperatingLeaseLiabilities`	$2.98M	USD	2 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$77.00K	USD	2 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$55.00K	USD	2 Qtrs
Unpaid deferred offering costs	`UnpaidDeferredOfferingCosts`	$1.80M	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Payments of Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$274.00K	USD	2 Qtrs
Payments of Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$274.00K	USD	1 Quarter
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-145.97M	USD	Point-in-time
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$6.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$7.00K	USD	2 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-41.00K	USD	2 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-14.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$96.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.00K	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$205.00K	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$205.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$57.00K	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$57.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$1.36M	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.90M	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$803.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$1.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-45.04M	USD	2 Qtrs
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-145.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.